cl 277082 has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bentzen, CL; Maechler, P; Niesor, E; Wollheim, CB | 2 |
2 other study(ies) available for cl 277082 and Alloxan Diabetes
| Article | Year |
|---|---|
Importance of exogenous cholesterol in diabetic rats: effects of treatment with insulin or with an acyl-CoA:cholesterol acyltransferase inhibitor.
Topics: Animals; Blood Glucose; Cholesterol; Cholesterol Esters; Cholesterol, Dietary; Cholesterol, LDL; Cholesterol, VLDL; Chylomicrons; Diabetes Mellitus, Experimental; Insulin; Intestine, Small; Liver; Male; Phenylurea Compounds; Rats; Rats, Wistar; Sterol O-Acyltransferase; Tritium | 1993 |
Role of the intestinal acyl-CoA:cholesterol acyltransferase activity in the hyperresponse of diabetic rats to dietary cholesterol.
Topics: Animals; Anticholesteremic Agents; Carbon Radioisotopes; Cholesterol; Cholesterol, Dietary; Diabetes Mellitus, Experimental; Injections, Intravenous; Intestines; Liver; Male; Microsomes; Phenylurea Compounds; Rats; Rats, Wistar; Sterol O-Acyltransferase | 1992 |